Institute former member Institute & ΏͺΤΖΜεΣύ alumni All authors Continuant Continuant Entity Entity Agent Independent Continuant 2025-05-06T21:20:13 RDF description of Pawloski, Pamala A., PharmD, BCOP, FCCP - http://repository.healthpartners.com/individual/person-Pawloski-P-A person-Pawloski-P-A public person-Pawloski-PA 2025-02-11T07:20:39 <p><strong>Joined the Institute:</strong> 2008</p> <p><strong>Education and training: </strong>PharmD, North Dakota State University; pharmacy practice residency and oncology pharmacy practice residency, University of Kentucky; clinical pharmacology fellowship, University of Texas M.D. Anderson Cancer Center.</p> <p><strong>Overview/research interests: </strong>Optimizing patient outcomes by improving medication management through the application of pharmacogenomics, medication therapy management and medication surveillance.</p> <p><strong>Current research activities and funding: </strong></p> <p><strong>Cancer Treatment and Supportive Care Outcomes </strong></p> <ul> <li>CRN4: Cancer Research Resources & Collaboration in Integrated Health Care Systems (NCI)</li> <li>Pilot Testing a Biorepository Framework to Enable Genomic Research at HP (HPI)</li> <li>Treatment, Experiences and Barriers among Elderly Colorectal Cancer Patients (PCORI)</li> <li>Implementing Universal Lynch Syndrome Screening across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizational Contexts (NCI)</li> </ul> <p><strong>Medication Safety and Adverse Event Surveillance</strong></p> <ul> <li>Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP) Maintenance (FDA)</li> <li>Evaluation of the Risk of Neural Tube Defects Among Live Births Exposed to Maternal Prescription Opioids During Early Pregnancy (FDA)</li> <li>FDA Sentinel Initiative (FDA)</li> <li>Innovation in Medical Evidence and Development Surveillance (IMEDS) Signal Refinement and Signal Characterization Bundles (public-private</li> <li>Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Comparative Effectiveness of Biosimilars (public-private)</li> </ul> Pawloski, Pamala A., PharmD, BCOP, FCCP